The relationship of APOE genotype to neuropsychological performance in long‐term cancer survivors treated with standard dose chemotherapy

The results of this study provide preliminary support for the hypothesis that the epsilon 4 allele of APOE may be a potential genetic marker for increased vulnerability to chemotherapy-induced cognitive decline.